California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on October 2, 2026

Oct. 2, 2026

Grammy-Winning Bassist Stanley Clarke Reflects on Losing Friends to Drugs and the Mentor Who Changed His Life

Indeterminate GlobeNewswire

Oct. 2, 2026

NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

Indeterminate GlobeNewswire

Oct. 2, 2026

Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Indeterminate GlobeNewswire

Oct. 2, 2026

Urban Decay Turns Canter’s Deli Into a One-Night-Only Underground Rave for Its Dirty 30

Indeterminate GlobeNewswire

Oct. 2, 2026

Securities Fraud Investigation Into ServiceTitan, Inc. (TTAN) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Indeterminate GlobeNewswire

Oct. 2, 2026

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Indeterminate GlobeNewswire

Oct. 2, 2026

ASHR Publishes Product Principles for Digital Wellness

Indeterminate EIN Presswire

Oct. 2, 2026

Securities Fraud Investigation Into The Cooper Companies, Inc. (COO) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Indeterminate GlobeNewswire

Oct. 2, 2026

Securities Fraud Investigation Into Coastal Financial Corporation (CCB) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Indeterminate GlobeNewswire

Oct. 2, 2026

iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits

Indeterminate GlobeNewswire

Oct. 2, 2026

Robbins LLP Reminds Investors of the Class Action Lawsuit Against Qfin Holdings, Inc. (QFIN)

Indeterminate GlobeNewswire

Oct. 2, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System

Indeterminate GlobeNewswire

Oct. 2, 2026

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Nihongo to English Celebrates One Year of Laughs, Language and the Art of Communicating Imperfectly

Indeterminate EIN Presswire